No Reason to Get Excited about Athenahealth (ATHN), Thinks Oppenheimer

Go back to No Reason to Get Excited about Athenahealth (ATHN), Thinks Oppenheimer

athenahealth, Inc. (ATHN) Tops Q4 EPS by 1c

February 7, 2013 4:02 PM EST

athenahealth, Inc. (NASDAQ: ATHN) reported Q4 EPS of $0.29, $0.01 better than the analyst estimate of $0.28. Revenue for the quarter came in at $116.3 million versus the consensus estimate of $116.97 million.

For earnings history and earnings-related data on athenahealth, Inc. (ATHN) click here.... More